Product Name:	Crizotinib
Synonyms:	3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-2-aMinopyridine;(R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylaMine;[3-[[(R)-1-(2,6-Dichloro-3- fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]aMine;2-PyridinaMine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-;Crozotinib;Crizotinib,PF-02341066;Xalkori;Crizotinib Xalkori
CAS:	877399-52-5
MF:	C21H22Cl2FN5O
MW:	450.34
EINECS:	638-814-9

Melting point	192 °C
Boiling point	599.2±50.0 °C(Predicted)
density	1.47±0.1 g/cm3(Predicted)
storage temp.	room temp
solubility	Soluble in DMSO (up to 25 mg/ml with warming) or in Ethanol (up to 25 mg/ml with warming)
form	powder
pka	9.81±0.10(Predicted)
color	white to tan
Stability:	Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 2 months.
CAS DataBase Reference	877399-52-5

Crizotinib

Company Profile Introduction